Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.
REDWOOD CITY, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today confirmed that on July 28, 2026, it received a further revised, unsolicited, non-binding acquisition proposal from Bradley L.
How this was made
The 30-second read
Why it matters
The key tradable element is the emergence of competing revised offers with specific cash-per-share terms and contingent value rights, which can shift takeover expectations and valuation multiples for SEER.
Market read
Competing revised buyout proposals increase the probability of a transaction process and can drive target-specific volatility until the committee’s response and any 8-K details are released.
What to watch
The competing offers differ in price and CVR structure, so traders should focus on the eventual 8-K letter details and any subsequent binding bid or process updates rather than the headline cash price alone.
Background
Seer is disclosing receipt of revised unsolicited acquisition proposals from two different parties, with the board’s Special Committee set to review.
Ticker impact
Seer confirms it received further revised unsolicited, non-binding acquisition proposals, including a $2.55 cash offer with contingent value rights.
Near-term volatility likely as investors reprice the likelihood and relative attractiveness of the competing offers.
The article discloses two revised unsolicited proposals with specific per-share cash prices and CVR structures, plus that the Special Committee will review; no stockholder action is required yet, so timing is uncertain but the catalyst is immediate.
Market effects
Reinforces that proteomics tools companies can attract takeover interest, but the article is company-specific and does not establish a broader sector catalyst.
Limited, as the event is centered on a single US-listed issuer.
Low, no cross-border transaction details beyond the US-listed target.
Counterpoint
Because both proposals are unsolicited and non-binding, the market may overestimate deal certainty; the committee could reject or negotiate without reaching a transaction.
Key entities
- companySeer, Inc.
Nasdaq-listed proteomics company that received revised unsolicited acquisition proposals and will have its Special Committee review them.
- acquirer_groupRadoff-JEC Group
Proposing to acquire Seer for $2.55 per share in cash plus a contingent value right, per the revised non-binding offer.
- individualOmid Farokhzad, M.D.
Seer Chair and CEO who submitted a revised unsolicited non-binding proposal to acquire Seer for $2.45 per share in cash plus two CVRs.
